Matsumura T, Taketa K, Shimoda S, Araki E
J Diabetes Investig. 2014; 3(1):11-23.
PMID: 24843540
PMC: 4014927.
DOI: 10.1111/j.2040-1124.2011.00182.x.
Hayashi T, Yamaguchi T, Sakakibara Y, Taguchi K, Maeda M, Kuzuya M
PLoS One. 2014; 9(2):e88391.
PMID: 24520379
PMC: 3919771.
DOI: 10.1371/journal.pone.0088391.
Sinno M, Al-Mallah M
Cardiol Res Pract. 2010; 2010:134564.
PMID: 20672024
PMC: 2909714.
DOI: 10.4061/2010/134564.
Dens J, Desmet W, Coussement P, De Scheerder I, Kostopoulos K, Kerdsinchai P
Heart. 2003; 89(8):887-92.
PMID: 12860866
PMC: 1767780.
DOI: 10.1136/heart.89.8.887.
Cattaruzza M, Wachter R, Wagner A, Hecker M
Br J Pharmacol. 2000; 129(6):1155-62.
PMID: 10725264
PMC: 1571958.
DOI: 10.1038/sj.bjp.0703192.
Endothelial dysfunction and hypertension.
Ferro C, Webb D
Drugs. 1997; 53 Suppl 1:30-41.
PMID: 9034753
DOI: 10.2165/00003495-199700531-00006.
Preventive effect of nicardipine on hyperplastic changes in venous bypass grafts.
Gokce O, Gokce C, Gunel S, Ozden A, Huseyinoglu K, Ucar O
World J Surg. 1993; 17(1):94-9; discussion 99-100.
PMID: 8447148
DOI: 10.1007/BF01655716.
Inhibitory effect of clentiazem (TA-3090), a new calcium antagonist, on balloon catheter-induced intimal thickening of rabbit aorta.
Saso Y, Ohtani A, Odawara A, Iwasaki H, Takashima K, Morita T
Cardiovasc Drugs Ther. 1993; 7(2):257-64.
PMID: 8357780
DOI: 10.1007/BF00878516.
Differential and interactive effects of calcium channel blockers and cholesterol content of the diet on jejunal uptake of lipids in rabbits.
Hyson D, Thomson A, Kappagoda C
Lipids. 1994; 29(4):281-7.
PMID: 8177021
DOI: 10.1007/BF02536333.
Inhibition of cholesteryl ester deposition in macrophages by calcium entry blockers: an effect dissociable from calcium entry blockade.
Daugherty A, Rateri D, Schonfeld G, Sobel B
Br J Pharmacol. 1987; 91(1):113-8.
PMID: 3594069
PMC: 1853476.
DOI: 10.1111/j.1476-5381.1987.tb08989.x.
'Second generation' dihydropyridine calcium antagonists. Greater vascular selectivity and some unique applications.
Freedman D, Waters D
Drugs. 1987; 34(5):578-98.
PMID: 3319491
DOI: 10.2165/00003495-198734050-00005.
Nicardipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy, in the treatment of angina pectoris, hypertension and related cardiovascular disorders.
Sorkin E, Clissold S
Drugs. 1987; 33(4):296-345.
PMID: 3297616
DOI: 10.2165/00003495-198733040-00002.
International nifedipine trial on antiatherosclerotic therapy (INTACT).
LICHTLEN P, Nellessen U, Rafflenbeul W, Jost S, Hecker H
Cardiovasc Drugs Ther. 1987; 1(1):71-9.
PMID: 3154311
DOI: 10.1007/BF02125836.
Verapamil and diet halt progression of atherosclerosis in cholesterol fed rabbits.
Sievers R, Rashid T, Garrett J, Blumlein S, Parmley W
Cardiovasc Drugs Ther. 1987; 1(1):65-9.
PMID: 3154310
DOI: 10.1007/BF02125835.
Clinical application of quantitative coronary angiography using the CAAS system: preliminary results of the INTACT study (International Nifedipine Trial on Antiatherosclerotic Therapy).
Jost S, Deckers J, Nellessen U, Rafflenbeul W, Hecker H, Reiber J
Int J Card Imaging. 1988; 3(2-3):75-86.
PMID: 3049846
DOI: 10.1007/BF01814880.
Suppression of rat carotid lesion development by the calcium channel blocker PN 200-110.
Handley D, Van Valen R, Melden M, Saunders R
Am J Pathol. 1986; 124(1):88-93.
PMID: 2942038
PMC: 1888187.
Noninvasive assessment of lipid disposition in treated and untreated atherosclerotic rabbits.
Deforge L, Schwendner S, DeGalan M, McConnell D, Counsell R
Pharm Res. 1989; 6(12):1011-6.
PMID: 2622856
DOI: 10.1023/a:1015918202142.
Effects of organic and inorganic Ca antagonists on rat platelet arachidonic acid metabolism in the presence of Ca2+, Sr2+ and Ba2+.
Blache D, Ciavatti M
Mol Cell Biochem. 1989; 85(2):191-6.
PMID: 2498642
DOI: 10.1007/BF00577114.
Retardation of development and progression of coronary atherosclerosis: a new indication for calcium antagonists?.
Schneider W, Kober G, Roebruck P, Noack H, Alle M, Cieslinski G
Eur J Clin Pharmacol. 1990; 39 Suppl 1:S17-23.
PMID: 2261941
International nifedipine trial on anti-atherosclerotic therapy (INTACT)--methodologic implications and results of a coronary angiographic follow-up study using computer-assisted film analysis.
Jost S, Deckers J, Rafflenbeul W, Hecker H, Reiber J, Nikutta P
Int J Card Imaging. 1990; 6(2):117-33.
PMID: 2097305
DOI: 10.1007/BF02398895.